Your browser is no longer supported. Please, upgrade your browser.
Settings
OCLS Oculus Innovative Sciences, Inc. daily Stock Chart
OCLS [NASD]
Oculus Innovative Sciences, Inc.
Index- P/E- EPS (ttm)-0.57 Insider Own0.40% Shs Outstand21.11M Perf Week1.98%
Market Cap21.74M Forward P/E- EPS next Y- Insider Trans6.29% Shs Float20.87M Perf Month25.61%
Income-8.80M PEG- EPS next Q- Inst Own10.10% Short Float3.32% Perf Quarter-14.17%
Sales15.50M P/S1.40 EPS this Y-256.90% Inst Trans0.99% Short Ratio1.85 Perf Half Y-18.25%
Book/sh0.55 P/B1.87 EPS next Y- ROA-63.70% Target Price3.00 Perf Year42.66%
Cash/sh0.29 P/C3.56 EPS next 5Y- ROE-81.30% 52W Range0.70 - 1.97 Perf YTD-10.43%
Dividend- P/FCF- EPS past 5Y19.50% ROI-92.70% 52W High-48.22% Beta1.13
Dividend %- Quick Ratio3.40 Sales past 5Y13.50% Gross Margin48.10% 52W Low45.71% ATR0.07
Employees34 Current Ratio4.00 Sales Q/Q18.70% Oper. Margin-57.20% RSI (14)52.68 Volatility4.49% 6.91%
OptionableNo Debt/Eq0.00 EPS Q/Q72.20% Profit Margin-56.30% Rel Volume0.70 Prev Close1.03
ShortableYes LT Debt/Eq0.00 EarningsMay 05 AMC Payout- Avg Volume374.67K Price1.02
Recom2.00 SMA203.68% SMA502.81% SMA200-9.86% Volume252,305 Change-0.97%
Jun-26-15Initiated Maxim Group Buy $3
Apr-19-13Reiterated Maxim Group Buy $2.80 → $6
Dec-14-10Initiated Rodman & Renshaw Mkt Outperform $3
Aug-18-09Initiated Dawson James Buy $4.50
Nov-07-08Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
Aug-06-08Reiterated Rodman & Renshaw Mkt Outperform $14 → $12
Apr-11-08Reiterated Rodman & Renshaw Mkt Outperform $16 → $14
Jul-18-07Reiterated Rodman & Renshaw Mkt Outperform $13 → $16
Jun-21-07Initiated Rodman & Renshaw Mkt Outperform $13
Mar-27-07Initiated Roth Capital Buy $10
May-03-16 04:05AM  Oculus Innovative Sciences Launches New Ceramax Skin Barrier Cream in the United States GlobeNewswire
Apr-28-16 04:05AM  Oculus Innovative Sciences to Present at Pioneers 2016 Investor Conference Hosted by Joseph Gunnar & Company in New York City GlobeNewswire
Apr-27-16 04:05AM  Oculus Innovative Sciences to Present at the Third Annual Growth Capital Expo MicroCap Investor Conference in Las Vegas GlobeNewswire
Apr-26-16 09:20AM  Data Shows Oculus Delivering on Promise to Grow U.S. Dermatology Sales Accesswire
Apr-20-16 02:35PM  Oculus Innovative Sciences Surges 26%: Here's Why Benzinga +18.28%
12:57PM  Top Stocks on 4/20: Investors Are Considering These on Wednesday April 20th Accesswire
10:07AM  4 Promising Small Cap Stocks That You Need To Know About Accesswire
04:05AM  Oculus Innovative Sciences Receives U.S. FDA Approval for Lasercyn for Use Following Laser Procedures, Microdermabrasions and Chemical Peels GlobeNewswire
Apr-13-16 04:05AM  Oculus Innovative Sciences Receives European Approval to Market Sinudox Indicated for Use in Nasal Irrigation GlobeNewswire
Apr-06-16 04:05AM  Oculus Innovative Sciences Strengthens Intellectual Property Portfolio With Allowance of New Patents for Microcyn® Technology GlobeNewswire
Mar-31-16 06:20AM  This University of Maryland spinoff just hit the market with its 3-D sound technology at bizjournals.com
Mar-30-16 04:15AM  Oculus Innovative Sciences and Lipogrid of Sweden Announce Strategic Collaboration for Topical Dermatology Drug Delivery at noodls
04:05AM  Oculus Innovative Sciences and Lipogrid of Sweden Announce Strategic Collaboration for Topical Dermatology Drug Delivery GlobeNewswire
Mar-24-16 04:22AM  Oculus Innovative Sciences to Present at the Sidoti Emerging Growth Conference at noodls
04:05AM  Oculus Innovative Sciences to Present at the Sidoti Emerging Growth Conference GlobeNewswire
Mar-23-16 04:07PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements
04:29AM  Oculus Innovative Sciences Announces Multi-Year Licensing Agreement with Manna Pro Products, LLC, for MicrocynAH® Animal Healthcare Products at noodls
04:05AM  Oculus Innovative Sciences Announces Multi-Year Licensing Agreement with Manna Pro Products, LLC, for MicrocynAH® Animal Healthcare Products GlobeNewswire
Mar-18-16 04:07PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements
08:41AM  Oculus Innovative Sciences Announces Pricing of $3.4 Million Underwritten Public Offering GlobeNewswire
Mar-17-16 07:42PM  Oculus Innovative Sciences Announces Proposed Underwritten Public Offering of Common Stock and Warrants GlobeNewswire -5.76%
Mar-09-16 03:05AM  Oculus Innovative Sciences to Present at the Roth Capital Partners 28th Annual Conference GlobeNewswire
Mar-08-16 09:25AM  Dermatologists Praise Multiple Benefits of Oculus Innovative Science's Microcyn Technology Accesswire
Mar-03-16 03:05AM  Oculus Innovative Sciences Receives European Approval to Market Lasercyn Indicated for Use Following Laser Skin Resurfacing GlobeNewswire
Feb-24-16 09:01AM  Stonegate Capital Partners Initiates Coverage on Oculus Innovative Sciences Accesswire
Feb-23-16 09:15AM  Addressing Antibiotic Resistance With Combination Therapies for Acne Accesswire
Feb-20-16 01:04PM  OCULUS INNOVATIVE SCIENCES, INC. Financials
Feb-18-16 04:05AM  Maxim Group Hosts Key Opinion Leaders Discussing Breakthroughs in Dermatology Relating to Products From Oculus Innovative Sciences GlobeNewswire
Feb-16-16 04:53PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-Q, Quarterly Report +5.32%
Feb-09-16 12:54PM  Oculus Innovative Sciences, Inc. Earnings Analysis: Q3, 2016 By the Numbers
09:25AM  Holding the Course, Oculus Innovative Sciences Delivers Revenue Growth Again Accesswire
Feb-08-16 12:19PM  Edited Transcript of OCLS earnings conference call or presentation 4-Feb-16 9:30pm GMT -17.86%
Feb-05-16 04:05AM  Oculus Innovative Sciences to Present at the Source Capital Group's 2016 Disruptive Growth & Healthcare Conference GlobeNewswire -9.68%
Feb-04-16 04:30PM  Oculus Innovative Sciences Inc Earnings Call scheduled for 4:30 pm ET today
04:06PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme
04:05PM  Oculus Innovative Sciences Reports Third Quarter Financial Results GlobeNewswire
07:07AM  Q3 2016 Oculus Innovative Sciences Inc Earnings Release - After Market Close
Jan-21-16 04:05AM  Oculus Innovative Sciences Announces Fiscal Third Quarter 2016 Financial Results and Conference Call GlobeNewswire +9.52%
Jan-20-16 09:25AM  A Turnaround Story Wall Street Hasn't Caught Onto Yet Accesswire
Jan-14-16 02:45PM  40 under 40: Meet the financial wizards and local economic development leaders (Video) at bizjournals.com
04:05AM  Oculus Innovative Sciences Receives European CE Mark for New MucoClyns for First Responders GlobeNewswire
Jan-13-16 04:45PM  40 under 40: Find out which real estate and legal leaders made the cut (Video) at bizjournals.com +6.74%
Jan-12-16 04:00PM  Announcing 40 Under 40's tech titans in the class of 2016 (Video) at bizjournals.com -7.29%
Jan-08-16 02:43PM  Edited Transcript of OCLS earnings conference call or presentation 5-Nov-15 9:30pm GMT -7.08%
12:13PM  12 Biotechs With Binary Events Coming This Year
06:50AM  8 things you need to know this morning at bizjournals.com
Jan-07-16 09:25AM  Innovation Sparks Advancement of New Treatments for Atopic Dermatitis Accesswire -5.04%
06:32AM  [$$] Fitbit flop shows the perils of new hardware at Financial Times
Jan-05-16 10:00AM  [$$] CES 2016: HTC tweaks virtual reality headset to give 'room scale' at Financial Times
Dec-22-15 09:30AM  The Zacks Analyst Blog Highlights: Streamline Health Solutions, WaferGen Bio-systems, HealthEquity, Oculus Innovative Sciences and LeMaitre Vascular
Dec-21-15 09:45AM  Santa Brings FDA and Health Canada Approvals for New Dermatology Products Accesswire
08:31AM  5 Growth Stocks to Buy on High Obamacare Enrollment
Dec-17-15 04:05AM  Oculus Innovative Sciences Receives FDA Clearance for Microcyn®-Based SebDerm Gel GlobeNewswire
Dec-03-15 11:19AM  Oculus Innovative Sciences, Inc. Earnings Q2, 2016
Dec-01-15 09:33AM  OCLSW: Compelling Leveraged Upside Potential With A Long Time To Expiry Accesswire
Nov-20-15 09:00AM  Samsungs Oculus-powered Gear VR is the Best Money Can Buy at Fortune
Nov-12-15 09:15AM  Oculus Innovative Sciences Beats Analyst Expectations, Even More than at First Blush Accesswire
Nov-10-15 04:17PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-Q, Quarterly Report
Nov-05-15 04:30PM  Oculus Innovative Sciences Inc Earnings Call scheduled for 4:30 pm ET today
04:07PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme
04:05PM  Oculus Innovative Sciences Reports Financial Results for the Second Quarter of Fiscal Year 2016 GlobeNewswire
Nov-03-15 12:08PM  Oculus Innovative Sciences, Inc. Value Analysis (NASDAQ:OCLS) : November 3, 2015
09:15AM  Earnings on Tap: Glu Mobile and Oculus Innovative Sciences Accesswire
Oct-27-15 04:48PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year,
Oct-22-15 05:21PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K/A, Submission of Matters to a Vote of Security Holders
06:05AM  Oculus Innovative Sciences Announces Fiscal Second Quarter 2016 Financial Results and Conference Call GlobeNewswire
Oct-20-15 09:10AM  Oculus Has Made Significant Gains In The Dermatology Industry After Just One Year Accesswire
Oct-16-15 05:00PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Oct-15-15 04:07PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Oct-08-15 09:27AM  Prescription Scar Gel Leads Oculus' Charge in Dermatology Accesswire
Oct-01-15 10:39AM  Oculus Innovative Sciences, Inc. Earnings Q1, 2016
Sep-27-15 12:44PM  Facebook 'dramatically' increases virtual reality spending at Financial Times
11:53AM  Oculus teams up with 20th Century Fox to bring virtual reality to movies at Fortune
Sep-24-15 06:05AM  Oculus Innovative Sciences Introduces MicrocynAH(R) Next-Generation Dermatology Products With Dimethicone for Animals GlobeNewswire +13.11%
Sep-15-15 04:11PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders
Sep-11-15 06:30PM  Oculus Innovative Sciences Announces Preliminary Results for Its 2015 Annual Meeting of Stockholders GlobeNewswire
Sep-09-15 09:13AM  Oculus Innovative Sciences Turnaround Positions Company in Lucrative Dermatology Market Accesswire
Aug-26-15 10:00AM  Alevicyn: A Better Approach in Treating Eczema Accesswire
Aug-25-15 09:50AM  Edited Transcript of OCLS earnings conference call or presentation 30-Jul-15 8:30pm GMT
Aug-19-15 06:05AM  Oculus Innovative Sciences Announces Introduction of Alevicyn SG Antipruritic Spray Gel for Relief of Pain and Itch in Atopic Dermatitis GlobeNewswire
Aug-13-15 10:28AM  As Oculus Heads Toward Record Revenue, The Stock Is Trading Cheaper Then Ever Accesswire +20.56%
Aug-09-15 08:13PM  10-Q for Oculus Innovative Sciences, Inc. at Company Spotlight
Aug-07-15 06:03PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 10-Q, Quarterly Report
Aug-05-15 09:51AM  Q1 Figures Show Oculus Innovative Sciences Executing Turnaround Plan Accesswire -7.75%
Jul-30-15 04:30PM  Oculus Innovative Sciences Inc Earnings Call scheduled for 4:30 pm ET today
04:18PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Stateme
04:05PM  Oculus Innovative Sciences Reports Financial Results for the First Quarter of Fiscal Year 2016 GlobeNewswire
07:07AM  Q1 2016 Oculus Innovative Sciences Inc Earnings Release - After Market Close
Jul-22-15 11:10AM  CONMED (CNMD) Posts Q2 Earnings, Revenue Miss; Down Y/Y - Analyst Blog
10:50AM  Neogen Tops Q4 Earnings, Revenue Estimates; Shares Surge - Analyst Blog
Jul-21-15 09:44AM  Oculus Innovative Sciences: The Cheapest Stock Available In An Active Dermatology Sector And A New Player In Atopic Dermatitis Accesswire
Jul-16-15 06:05AM  Oculus Innovative Sciences Announces Fiscal First Quarter 2016 Financial Results and Conference Call GlobeNewswire
Jul-14-15 09:25AM  A Dozen Reasons To Love Dermatology Companies Accesswire
Jul-09-15 10:10AM  Company News for July 09, 2015 - Corporate Summary
Jul-08-15 02:40PM  LabCorp, Epic Sciences Ink Deal for Oncology Testing in Asia - Analyst Blog
11:03AM  Occulus Innovative Sciences (OCLS) Stock Spikes After Receiving New U.S. Patent at TheStreet
06:05AM  Oculus Innovative Sciences Receives New U.S. Patent for Microcyn(R) Technology in Treatment of Atopic Dermatitis GlobeNewswire
Jul-02-15 04:06PM  OCULUS INNOVATIVE SCIENCES, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders +5.56%
Jun-26-15 07:26AM  Coverage initiated on Oculus Innovative Sciences by Maxim Group
Jun-18-15 08:09PM  10-K for Oculus Innovative Sciences, Inc. at Company Spotlight
Oculus Innovative Sciences, Inc. designs, produces, and markets prescription and over-the-counter products based on its Microcyn platform technology for the dermatology, surgical, advanced tissue and skin care, and animal healthcare markets in the United States, Mexico, Europe, and internationally. The Microcyn platform technology is based on electrically charged oxychlorine small molecules, which are designed to target a range of pathogens that cause disease, including viruses, fungi, spores, and antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus, as well as Clostridium difficile, a highly contagious bacteria spread by human contact. It offers Microcyn-based human dermatology and advanced tissue care products as prescription and over-the-counter products; and Microcyn technology-based animal healthcare products under the Vetericyn brand. The company's Microcyn has received ten 510(k) clearances for use as a medical device in wound care management, including for acute and chronic wounds, and in dermatology applications. In addition, it provides consulting and laboratory services to medical companies that design and manufacture biomedical devices and drugs. Oculus Innovative Sciences, Inc. sells its products directly to third parties, and through contract sales organization and distributors to hospitals, physicians, nurses, and other healthcare practitioners, as well as to dermatologists for the treatment of various skin afflictions. Oculus Innovative Sciences, Inc. has a strategic collaborative agreement with the Lipogrid Company of Sweden to develop multiple topical drug delivery formulations. The company was formerly known as Micromed Laboratories, Inc. and changed its name to Oculus Innovative Sciences, Inc. in August 2001. Oculus Innovative Sciences, Inc. was incorporated in 1999 and is headquartered in Petaluma, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Schutz James JChief Executive OfficerFeb 25Buy1.005,0005,00025,885Feb 29 06:00 AM